THE EUROPEAN COMMUNITY; REPRESENTED BY THE EUROPEAN COMMISSION
发明人:
MORGENSTERN, ALFRED,APOSTOLIDIS, CHRISTOS,MOLINET, ROGER,LUETZENKIRCHEN, KLAUS
申请号：
CA2570191
公开号：
CA2570191C
申请日:
2005.06.24
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The use of Th-226 or mother radionuclides thereof, namely U-230 or Ac-226, inmedicine is proposed. These radionuclides are particularly appropriate for thetreatment of human and/or non-human mammals, in particular for therapeutic,diagnostic (detection/imaging), prophylactic and pain palliation purposes.Depending on the applications, these radionuclides may be used in variousforms for treatment and/or diagnostic purposes, in particular in cationic formor in the form of radioconjugates or bone-targeting complexes. Methods ofproduction of these radionuclides are also disclosed.
